- Benign tumor
- Esophageal cancer
- Gastrointestinal cancer
- Rectal cancer
- Proton therapy
Publications
Hannah Roberts, Theodore Hong, Zoe Guan, Beow Yeap, Edgar Ben-Josef, Andrew Zhu, Lipika Goyal, Joseph Franses, David Ryan, Jill Allen, Jeffrey Clark, Leilana Ly, Lorraine Drapek, Kenneth Tanabe, Cristina Ferrone, Eugene Koay, Christopher Crane, Thomas DeLaney, Dan Duda, and Jennifer Wo Long-Term Outcomes and Biomarker Correlates of a Multi-Institutional Phase II Study of Hypofractionated Proton Beam Therapy for Unresectable Primary Liver Tumors , Clinical Cancer Research: 2026
Andy Minn, Yuwei Qi, Taewon Yoon, Uri Amit, Brian Kim, Jacob Shabason, Olivia Oldridge, Jesse Donovan, Alexei Korennykh, Erica Carpenter, Thomas Karasic, and Edgar Ben-Josef Radiation Activates RNASEL to Enhance Immunotherapy by Disrupting a Circular RNA Checkpoint for Immunotransmission , In review: Cancer Cell: 2026
Avinash Ramkissoon, Uri Amit, Miguel Perez-Guillermo Cuev, Kevin Risolo, Cecilia Jiang, Karishma Khullar, Edgar Ben-Josef Impact of Gross Tumor Volume (GTV) and Effective Uniform Dose (EUD) on Clinical Outcomes after SBRT for Hepatocellular Carcinoma (HCC) , Annual Meeting Proceedings ASTRO 2026: 2026
Uri Amnit et al. FLASH Proton Radiotherapy Preserves Ocular Structure and Function Without Compromising Antitumor Efficacy , Int J Radiat Oncol Biol Phys, S0360-3016(26)04233-1: 2026
Edgar Ben-Josef 1, Andrew M Lowy 2 A Novel Adjuvant Chemoradiotherapy/Immunotherapy for Resected Biliary Cancer , JAMA Oncol: 2025
Uri Amit 1 2, James M Metz 2, John P Plastaras 2, Rohi Gheewala 2, Ursina Teitelbaum 3, Nevena Damjanov 3, Charles Vollmer 4, Charles J Schneider 3, Major Kenneth Lee 4th 4, Mark O'Hara 3, Kim Reiss-Binder 3, Erica L Carpenter 3, Thomas B Karasic 3, Andre Konski 2, E Paul Wileyto 5, Edgar Ben-Josef 2 A phase 1 dual-dose escalation study of radiation and nab-paclitaxel in patients with unresectable and borderline resectable pancreatic cancer , Cancer, 131(12): 2025,e35936
Grace Lee 1, Bailey Nelson 2, Julie Koenig 1, John P Plastaras 3, James M Metz 3, Beow Y Yeap 4, Yongbin Zhang 2, Lorraine C Drapek 1, Christian Baglini 4, David P Ryan 4, Aparna R Parikh 4, Jill N Allen 4, Jeffrey W Clark 4, Lawrence S Blaszkowsky 4, Edgar Ben-Josef 3, Theodore S Hong 1, Jordan R Kharofa 5, Jennifer Y Wo 6 Long-term Outcomes of Definitive Chemoradiation With Proton Therapy for Treatment of Carcinoma of the Anal Canal: Combined Analysis of Two Prospective Trials , Int J Radiat Oncol Biol Phys, 122(1): 2025
Timothy J Brown 1, Uri Amit 2, Rohi Gheewala 2, Edgar Ben-Josef 2, Thomas B Karasic 2 Evaluating the Safety and Efficacy of Adding Liver-Directed Radiation Therapy to Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma: A Single-Center Retrospective Cohort Analysis , Am J Clin Oncol, 10.1097/COC.0000000000001214: 2025
Andrea Facciabene et al. Gut-targeted antibiotic modulation enhances radiotherapy in NSCLC: new epigenetic and dendritic cell functional correlates from a randomized pilot trial. , SITC 40th Anniversary Annual Meeting: 2025
Steven Joel Feigenberg 1, Francesca Costabile 1, Ceylan Tanes 2, Kyle Bittinger 2, Roderick O'Connor 3, Divyansh Agarwal 4, Giorgos Skoufos 5, Silavano Salaris 6, Artemis Hatzigeorgiou 5, Nektarios Kostopoulos 1, Shane Lloyd 7, Cole Friedes 1, Lisha Chen 1, Nikhil Yegya-Raman 1, Keith Cengel 1, William Levin 1, Bakir Valentić 3, Tyler Quarton 8, Alexander A Shestov 9, Abigail Berman 10, Jeffrey Bradley 1, Amit Maity 7, Costantinos Koumenis 1, Edgar Ben-Josef 1, Andrea Facciabene 11 12 Enhancing outcomes in medically inoperable early-stage NSCLC with gut-targeted antibiotics and stereotactic body radiotherapy: results from a randomized pilot study , J Immunother Cancer, 13(7): 2025